|
GPI Lipid Anchor Project | |
| Mutation | prediction results | |||||
|---|---|---|---|---|---|---|
| protein | site | tail | rest | with GPI-anchor | no GPI-anchor | accuracy |
| DAF | x | x | x | 4/5 | 1/1 | 83.3% |
| hGH-DAFx | x | x | 5/5 | 1/1 | 92.9% | |
| hGH-DAF28x | x | x | 3/3 | |||
| hGH-xDAFx | x | x | 0/1 | 4/4 | ||
| hGH-DAF29x group 1 | x | 5/5 | 84.2% | |||
| hGH-DAF29x group 2 | x | 0/2 | 1/2 | |||
| hGH-DAF29x group 3 | x | 10/10 | ||||
| hGH_VSG | x | 0/4 | 0.0% | |||
| PLAP I | x | 14/16 | 14/17 | 84.8% | ||
| PLAP II | x | 2/3 | 4/5 | 75.0% | ||
| Folate Receptor I | x | x | x | 3/3 | 2/3 | 91.2% |
| Folate Receptor II | x | 8/8 | ||||
| Folate Receptor III | x | x | 4/4 | |||
| Folate Receptor IV | x | 5/6 | ||||
| Folate Receptor V | x | x | x | 6/7 | ||
| Folate Receptor VI | x | 2/2 | 1/1 | |||
| ACES_TORCA | x | x | x | 12/12 | 4/4 | 100.0% |
| ACES_HUMAN I | x | 6/6 | 4/4 | 100.0% | ||
| ACES_HUMAN II | x | 16/19 | 14/16 | 85.7% | ||
| CD46 (fusion) | x | x | x | 26/35 | 2/5 | 70.0% |
| THY1 | x | 4/4 | 2/3 | 85.7% | ||
| CAH4 | x | 2/2 | 2/2 | 100.0% | ||
| 5'-NTD | x | x | 10/10 | 5/7 | 88.2% | |
| FA10_PLAP | x | x | x | 6/8 | 3/4 | 75.0% |
| miniPLAP | x | 3/3 | 100.0% | |||
| MP/uPAR | x | 11/12 | 5/6 | 88.9% | ||
| LY6A | x | x | 4/5 | 4/8 | 61.6% | |
| 158/187 | 86/106 | |||||
| 84.5% | 81.1% | |||||
| total | 244/293 | 83.3% | ||||
Last modified: 13th June 2002